Skip to main content
. 2023 Feb 25;13:3266. doi: 10.1038/s41598-023-30017-z

Table 4.

Multivariable Cox models of OS in relation to time to AT from SEER-Medicare and NCDBa,b.

Predictors Biopsy (N = 1232) Resection (N = 1927) Total (N = 3159)
aHR 95%CI P aHR 95%CI P aHR 95%CI P
SEER-Medicare, N = 3159a
 Time to AT, days
  ≤ 15 1.00 1.00 1.00
  16–26 1.03 0.88–1.20 0.706 0.90 0.78–1.02 0.105 0.97 0.87–1.07 0.496
  27–37 1.04 0.89–1.23 0.608 0.74 0.64–0.84  < 0.001 0.86 0.78–0.96 0.005
  ≥ 38 0.86 0.73–1.01 0.068 0.81 0.71–0.92 0.002 0.86 0.78–0.95 0.004
 Time to AT, cutoff as 27 days
  < 27 1.00 1.00 1.00
  ≥ 27 0.93 0.83–1.05 0.225 0.82 0.74–0.90  < 0.001 0.88 0.82–0.94  < 0.001
Predictors Biopsy (N = 1316) Resection (N = 6845) Total (N = 8161)
aHR 95%CI P aHR 95%CI P aHR 95%CI P
NCDB, N = 8161b
 Time to AT, days
  ≤ 15 1.00 1.00 1.00
  16–26 0.95 0.75–1.20 0.676 0.95 0.84–1.06 0.350 0.95 0.85–1.05 0.321
  27–37 0.85 0.68–1.06 0.153 0.83 0.74–0.93 0.001 0.83 0.75–0.92  < 0.001
  ≥ 38 0.77 0.61–0.97 0.024 0.87 0.77–0.98 0.017 0.85 0.77–0.94 0.002
 Time to AT, cutoff as 27 days
  < 27 1.00 1.00 1.00
  ≥ 27 0.84 0.74–0.95 0.006 0.89 0.84–0.94  < 0.001 0.88 0.83–0.93  < 0.001

AT adjuvant therapy, HR hazard ratio, 95% CI 95% confidence interval.

aAdjusted time to AT, age at diagnosis, gender, period, race/ethnicity, marital status, residence, education, income, registry location, surgery, AT, and Charlson Comorbidity Score by using multivariable Cox proportional models in SEER-Medicare.

bAdjusted time to AT, age at diagnosis, gender, period, race/ethnicity, residence, education, income, insurance, facility location, distance, care transition, surgery, AT, and Charlson/Deyo score by using multivariable Cox proportional models in NCDB.